Zimmer Partners, LP Kymera Therapeutics, Inc. Transaction History

Zimmer Partners, LP

  • $4.61 Billion
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$28.07 - $87.83 $350,875 - $1.1 Million
-12,500 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$26.1 - $33.28 $326,250 - $416,000
12,500 New
12,500 $404,000

Others Institutions Holding KYMR

# of Institutions
164
Shares Held
63.1M
Call Options Held
39.7K
Put Options Held
9.7K
View Full List

About Kymera Therapeutics, Inc.

KYMR Quotes by TradingView
  • Ticker KYMR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,705,800
  • Market Cap $1.65B
  • Description
  • Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...
More about KYMR
Track This Portfolio

Track Zimmer Partners, LP Portfolio

Follow Zimmer Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zimmer Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Zimmer Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email